(Q45670616)

English

Unravelling drug reimbursement outcomes: a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision making

scientific article published in September 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Unravelling drug reimbursement outcomes: a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision making (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

decision making

1 reference

based on heuristic

inferred from title

object named as

Frank Sandmann

3

0 references

author name string

Margreet Franken

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Fredrik Nilsson

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Anthonius de Boer

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Marc Koopmanschap

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

781-797

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committees

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Priority setting for orphan drugs: an international comparison

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

A comparison of pharmaceutical reimbursement agencies' processes and methods in France and Scotland

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994-2004.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Similarities and differences between five European drug reimbursement systems

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

European drug reimbursement systems' legitimacy: five-country comparison and policy tool

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Increasing marginal utility of small increases in life-expectancy? Results from a population survey.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

Economic evaluation and health care decision-making.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0074-1

21 January 2018

“Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What criteria for pharmaceuticals reimbursement? An empirical analysis of the evaluation of "medical service rendered" by reimbursable drugs in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The increasingly complex fourth hurdle for pharmaceuticals

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Priority-setting decisions for new cancer drugs: a qualitative case study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23839699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-013-0074-1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45670616&oldid=2207267950"